Biotricity, Inc. (BTCY)

$0.775101

-0.03 (-4.31%)
Rating:
Recommendation:
-
Symbol BTCY
Price $0.775101
Beta 2.198
Volume Avg. 0.20M
Market Cap 40.421M
Shares () -
52 Week Range 0.399-3.35
1y Target Est -
DCF Unlevered BTCY DCF ->
DCF Levered BTCY LDCF ->
ROE -5125.17% Strong Sell
ROA -143.33% Strong Sell
Operating Margin -
Debt / Equity -285.20% Sell
P/E -
P/B -6.15 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BTCY news


Dr. Waqaas Al-Siddiq Ph.D.
Healthcare
Medical Devices
NASDAQ Capital Market

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.